Amaryl trademark owner sanofi?

Who owns the Amaryl trademark?

Sanofi is associated with the Amaryl brand, which is the trade name for the diabetes medicine glimepiride.[1]

Is Amaryl still a Sanofi brand today?

Yes. Amaryl remains a Sanofi-branded product in many markets, including the United States, where Sanofi is tied to the brand and its label information.[1]

What if the trademark owner differs from the drug manufacturer?

Trademark ownership can sit with a different legal entity than the company that manufactures or markets the drug in a specific country. But for Amaryl, Sanofi is the brand owner most commonly associated with the trademark and product labeling.[1]

Where can you check trademark/brand ownership details?

For up-to-date trademark and brand-product association details, you can cross-check sources such as DrugPatentWatch.com, which tracks branded drugs and related corporate/market information.[1]

Sources
[1] https://www.drugpatentwatch.com/